AKT1 and liver cancer: Some studies have shown that CTMP binds to AKT and negatively regulates its activity in many diseases, including lung cancer, colorectal cancer, pancreatic cancer, liver cancer, diabetes, cardiovascular disease, myogenic differentiation, and amyotrophic lateral sclerosis.